MEDP

SEC source: 0000892251-23-000073 · form4.xml · nonDerivative · entry 1

Carley Brian T · CIK 0001677791 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,607

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

SEC source: 0000892251-23-000075 · form4.xml · derivative · entry 2

Kraft Robert O. · CIK 0001558592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 188

Underlying: Common Stock · 94 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

F2 · derivative.exercise_date: On December 9, 2022, the Reporting Person was granted 376 restricted stock units, vesting in four equal installments on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023.

F2 · derivative.expiration_date: On December 9, 2022, the Reporting Person was granted 376 restricted stock units, vesting in four equal installments on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023.

SEC source: 0000892251-23-000075 · form4.xml · nonDerivative · entry 1

Kraft Robert O. · CIK 0001558592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 188

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

SEC source: 0000892251-23-000074 · form4.xml · derivative · entry 2

McCarthy Cornelius P. III · CIK 0001750355 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 164

Underlying: Common Stock · 82 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

F2 · derivative.exercise_date: On December 9, 2022, the Reporting Person was granted 328 restricted stock units, vesting in four equal installments on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023.

F2 · derivative.expiration_date: On December 9, 2022, the Reporting Person was granted 328 restricted stock units, vesting in four equal installments on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023.

SEC source: 0000892251-23-000074 · form4.xml · nonDerivative · entry 1

McCarthy Cornelius P. III · CIK 0001750355 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 164

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

SEC source: 0000892251-23-000072 · form4.xml · derivative · entry 2

Carley Brian T · CIK 0001677791 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,400 shares

Expires 2023-08-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: This option vested in multiple tranches and was fully vested on June 1, 2017.

SEC source: 0000892251-23-000072 · form4.xml · nonDerivative · entry 1

Carley Brian T · CIK 0001677791 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,504

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000892251-23-000071 · form4.xml · nonDerivative · entry 1

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 6,233,019

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on February 20, 2023.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $220.00 to $222.585. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0000892251-23-000070 · form4.xml · nonDerivative · entry 1

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,233,019

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2023.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $220.00 to $222.585. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0000892251-23-000069 · form4.xml · nonDerivative · entry 2

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 6,282,366

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on February 20, 2023.

F4 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $220.00 to $226.26. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0000892251-23-000068 · form4.xml · nonDerivative · entry 2

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,282,366

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2023.

F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $220.00 to $226.26. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0000892251-23-000069 · form4.xml · nonDerivative · entry 1

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 6,392,690

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on February 20, 2023.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $220.00 to $221.75. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0000892251-23-000068 · form4.xml · nonDerivative · entry 1

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,392,690

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2023.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $220.00 to $221.75. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0000892251-23-000059 · form4.xml · derivative · entry 2

DAVENPORT FRED B JR · CIK 0001181154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,769

Underlying: Common Stock · 1,769 shares

Expires 2030-05-19

F2 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.

SEC source: 0000892251-23-000061 · form4.xml · derivative · entry 2

Carley Brian T · CIK 0001677791 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,769

Underlying: Common Stock · 1,769 shares

Expires 2030-05-19

F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.

SEC source: 0000892251-23-000057 · form4.xml · derivative · entry 1

Gwadry-Sridhar Femida H. · CIK 0001961974 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,769

Underlying: Common Stock · 1,769 shares

Expires 2030-05-19

F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.

SEC source: 0000892251-23-000055 · form4.xml · derivative · entry 1

Keating Ashley M. · CIK 0001777217 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,769

Underlying: Common Stock · 1,769 shares

Expires 2030-05-19

F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.

SEC source: 0000892251-23-000053 · form4.xml · derivative · entry 2

McCarthy Cornelius P. III · CIK 0001750355 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,769

Underlying: Common Stock · 1,769 shares

Expires 2030-05-19

F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.

SEC source: 0000892251-23-000051 · form4.xml · derivative · entry 2

Kraft Robert O. · CIK 0001558592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,769

Underlying: Common Stock · 1,769 shares

Expires 2030-05-19

F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.

SEC source: 0000892251-23-000044 · form4.xml · nonDerivative · entry 1

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,451,371

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2023.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $220.00 to $230.94. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0000892251-23-000046 · form4.xml · nonDerivative · entry 1

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 6,451,371

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on February 20, 2023.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $220.00 to $230.94. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0000892251-23-000025 · form4.xml · derivative · entry 2

Carley Brian T · CIK 0001677791 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 309

Underlying: Common Stock · 104 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

F2 · derivative.exercise_date: On December 9, 2022, the Reporting Person was granted 413 restricted stock units, vesting in four approximately equal installments on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023.

F2 · derivative.expiration_date: On December 9, 2022, the Reporting Person was granted 413 restricted stock units, vesting in four approximately equal installments on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023.

SEC source: 0000892251-23-000025 · form4.xml · nonDerivative · entry 1

Carley Brian T · CIK 0001677791 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 104

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

SEC source: 0000892251-23-000027 · form4.xml · derivative · entry 2

McCarthy Cornelius P. III · CIK 0001750355 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 246

Underlying: Common Stock · 82 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

F2 · derivative.exercise_date: On December 9, 2022, the Reporting Person was granted 328 restricted stock units, vesting in four equal installments on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023.

F2 · derivative.expiration_date: On December 9, 2022, the Reporting Person was granted 328 restricted stock units, vesting in four equal installments on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023.

SEC source: 0000892251-23-000027 · form4.xml · nonDerivative · entry 1

McCarthy Cornelius P. III · CIK 0001750355 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

SEC source: 0000892251-23-000029 · form4.xml · derivative · entry 2

Kraft Robert O. · CIK 0001558592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 282

Underlying: Common Stock · 94 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

F2 · derivative.exercise_date: On December 9, 2022, the Reporting Person was granted 376 restricted stock units, vesting in four equal installments on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023.

F2 · derivative.expiration_date: On December 9, 2022, the Reporting Person was granted 376 restricted stock units, vesting in four equal installments on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023.

SEC source: 0000892251-23-000029 · form4.xml · nonDerivative · entry 1

Kraft Robert O. · CIK 0001558592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

SEC source: 0001567619-23-003517 · doc1.xml · derivative · entry 2

Brady Kevin M. · CIK 0001877121 · CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

Underlying: Common Stock · 1,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

F2 · derivative.exercise_date: The restricted stock units vest in full on the fourth anniversary of the grant date or February 17, 2027, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.

F2 · derivative.expiration_date: The restricted stock units vest in full on the fourth anniversary of the grant date or February 17, 2027, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.

SEC source: 0001567619-23-003519 · doc1.xml · derivative · entry 2

EWALD STEPHEN P · CIK 0001677297 · General Counsel & Corp. Secy.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

Underlying: Common Stock · 1,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

F2 · derivative.exercise_date: The restricted stock units vest in full on the fourth anniversary of the grant date or February 17, 2027, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.

F2 · derivative.expiration_date: The restricted stock units vest in full on the fourth anniversary of the grant date or February 17, 2027, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.

SEC source: 0001567619-23-003516 · doc1.xml · derivative · entry 2

BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

Underlying: Common Stock · 1,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

F2 · derivative.exercise_date: The restricted stock units vest in full on the fourth anniversary of the grant date or February 17, 2027, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.

F2 · derivative.expiration_date: The restricted stock units vest in full on the fourth anniversary of the grant date or February 17, 2027, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.

SEC source: 0001567619-23-003514 · doc1.xml · derivative · entry 2

GEIGER JESSE J · CIK 0001677399 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

Underlying: Common Stock · 1,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

F2 · derivative.exercise_date: The restricted stock units vest in full on the fourth anniversary of the grant date or February 17, 2027, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.

F2 · derivative.expiration_date: The restricted stock units vest in full on the fourth anniversary of the grant date or February 17, 2027, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.

SEC source: 0001567619-23-003510 · doc1.xml · derivative · entry 3

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

Underlying: Common Stock · 1,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

F3 · derivative.exercise_date: The restricted stock units vest in full on the fourth anniversary of the grant date or February 17, 2027, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.

F3 · derivative.expiration_date: The restricted stock units vest in full on the fourth anniversary of the grant date or February 17, 2027, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.

SEC source: 0001567619-23-000977 · doc1.xml · derivative · entry 1

Gwadry-Sridhar Femida H. · CIK 0001961974 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 573

Underlying: Common Stock · 573 shares

Expires 2030-01-16

F1 · derivative.exercise_price: The exercise price is the closing price on January 13, 2023 as January 16, 2023 was not a trading day.

F2 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.

SEC source: 0001567619-22-021538 · doc1.xml · derivative · entry 1

Carley Brian T · CIK 0001677791 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 413

Underlying: Common Stock · 413 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

F2 · derivative.exercise_date: The restricted stock units vest in four approximately equal installments on March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023.

F2 · derivative.expiration_date: The restricted stock units vest in four approximately equal installments on March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023.

SEC source: 0001567619-22-021540 · doc1.xml · derivative · entry 1

Kraft Robert O. · CIK 0001558592 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 376

Underlying: Common Stock · 376 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

F2 · derivative.exercise_date: The restricted stock units vest in four equal installments on March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023.

F2 · derivative.expiration_date: The restricted stock units vest in four equal installments on March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023.

SEC source: 0001567619-22-021539 · doc1.xml · derivative · entry 1

McCarthy Cornelius P. III · CIK 0001750355 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 328

Underlying: Common Stock · 328 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

F2 · derivative.exercise_date: The restricted stock units vest in four equal installments on March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023.

F2 · derivative.expiration_date: The restricted stock units vest in four equal installments on March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023.

SEC source: 0001567619-22-020559 · doc1.xml · nonDerivative · entry 2

Brady Kevin M. · CIK 0001877121 · CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,000

SEC source: 0001567619-22-020559 · doc1.xml · nonDerivative · entry 1

Brady Kevin M. · CIK 0001877121 · CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,344

F1 · shares: Represents shares sold to satisfy tax withholding obligations upon the vesting of restricted stock units previously granted to the Reporting Person.

SEC source: 0001567619-22-020558 · doc1.xml · derivative · entry 3

GEIGER JESSE J · CIK 0001677399 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,000 shares

Expires 2024-03-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Each option vested on March 15, 2021.

SEC source: 0001567619-22-020558 · doc1.xml · nonDerivative · entry 2

GEIGER JESSE J · CIK 0001677399 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,382

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

SEC source: 0001567619-22-020558 · doc1.xml · nonDerivative · entry 1

GEIGER JESSE J · CIK 0001677399 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,382

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

SEC source: 0001567619-22-019121 · doc1.xml · derivative · entry 3

Kraft Robert O. · CIK 0001558592 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,630 shares

Expires 2023-08-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option vested in multiple tranches and was fully vested on June 1, 2017.

SEC source: 0001567619-22-019121 · doc1.xml · nonDerivative · entry 2

Kraft Robert O. · CIK 0001558592 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $220.00 to $223.54. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001567619-22-019121 · doc1.xml · nonDerivative · entry 1

Kraft Robert O. · CIK 0001558592 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,630

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001567619-22-018948 · doc1.xml · derivative · entry 3

EWALD STEPHEN P · CIK 0001677297 · General Counsel & Corp. Secy.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,500 shares

Expires 2025-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option vested on February 28, 2022.

SEC source: 0001567619-22-018948 · doc1.xml · nonDerivative · entry 2

EWALD STEPHEN P · CIK 0001677297 · General Counsel & Corp. Secy.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,854

SEC source: 0001567619-22-018948 · doc1.xml · nonDerivative · entry 1

EWALD STEPHEN P · CIK 0001677297 · General Counsel & Corp. Secy.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,354

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001567619-22-017774 · doc1.xml · nonDerivative · entry 1

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,483,019

F1 · kind: The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2022, as amended on May 3, 2022 and August 15, 2022.

F2 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions ranging from $152.49 to $156.06. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001567619-22-017772 · doc1.xml · nonDerivative · entry 1

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 6,483,019

F1 · kind: The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 17, 2022, as amended on May 3, 2022 and August 15, 2022.

F2 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions ranging from $152.49 to $156.06. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001567619-22-017725 · doc1.xml · nonDerivative · entry 2

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 6,425,593

F1 · kind: The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 17, 2022, as amended on May 3, 2022 and August 15, 2022.

F4 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions ranging from $157.83 to $163.71. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.